• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by Churchill Capital Corp X

    2/12/26 5:09:12 PM ET
    $CCCX
    Blank Checks
    Finance
    Get the next $CCCX alert in real time by email
    425 1 d104917d425.htm 425 425
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 12, 2026

     

     

    CHURCHILL CAPITAL CORP X

    (Exact name of registrant as specified in its charter)

     

     

     

    Cayman Islands   001-42646   86-1946291

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

      (I.R.S. Employer
    Identification No.)

    640 Fifth Avenue, 14th Floor

    New York, NY 10019

    (Address of principal executive offices, including zip code)

    Registrant’s telephone number, including area code: (212) 380-7500

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☒

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Title of each class

     

    Trading
    Symbol

     

    Name of each exchange
    on which registered

    Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant   CCCXU   The Nasdaq Stock Market LLC
    Class A ordinary shares, par value $0.0001 per share   CCCX   The Nasdaq Stock Market LLC
    Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share   CCCXW   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.07

    Submission of Matters to a Vote of Security Holders.

    As previously announced, on September 8, 2025, Churchill Capital Corp X, a Cayman Islands exempted company (“Churchill”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), by and among Churchill, AH Merger Sub I, Inc., a Delaware corporation and direct, wholly-owned subsidiary of Churchill, AH Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of Churchill, and ColdQuanta, Inc. (d/b/a Infleqtion), a Delaware corporation (“Infleqtion”). Pursuant to the Merger Agreement, the parties have agreed to consummate certain transactions (collectively, the “Business Combination”), subject to the terms and conditions of the Merger Agreement.

    On January 23, 2026, in connection with the Business Combination, Churchill and Infleqtion jointly filed with the U.S. Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-4 (No. 333-295282) (as amended from time to time, the “Registration Statement”) containing a proxy statement/prospectus (such proxy statement/prospectus in definitive form, the “Proxy Statement”), which Registration Statement was declared effective by the SEC on January 23, 2026, and Churchill commenced mailing the Proxy Statement on January 23, 2026.

    On February 12, 2026, Churchill held an extraordinary general meeting of its shareholders (the “Shareholder Meeting”), at which holders of 13,920,167 Class A Ordinary Shares and 10,350,000 Class B Ordinary Shares (collectively, the “Ordinary Shares”) as of January 13, 2026, the record date for the Shareholder Meeting, were present in person, virtually over the internet or by proxy, representing approximately 46.629% of the voting power of the Ordinary Shares as of the record date, and constituting a quorum for the transaction of business at the Shareholder Meeting. The proposals listed below are described in more detail in the Proxy Statement.

    At the Shareholder Meeting, the shareholders approved the Business Combination Proposal, the Domestication Proposal, the Organizational Documents Proposal, the Advisory Organizational Documents Proposal, the Stock Issuance Proposal, the Incentive Plan Proposal, the ESPP Proposal and the Director Election Proposal (each as defined in the Proxy Statement, and collectively, the “Shareholder Proposals”), which Shareholder Proposals are further described on pages 146 – 248 of the Proxy Statement, which are hereby incorporated by reference herein.

    The voting results for each of the Shareholder Proposals were as follows:

    Proposal No. 1: The Business Combination Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    22,111,101    2,140,329    18,737

    Proposal No. 2: The Domestication Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    21,974,462    2,148,652    147,053

    Proposal No. 3: The Organizational Documents Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    21,677,688    2,439,682    152,797

    Proposal No. 4: The Advisory Organizational Documents Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    21,051,136    3,074,972    144,059

     


    Proposal No. 5: The Stock Issuance Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    21,979,976

      

    2,147,712

      

    142,479

    Proposal No. 6: The Incentive Plan Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    21,578,599

      

    2,531,445

      

    160,123

    Proposal No. 7: The ESPP Proposal

     

    Ordinary Shares Voted For

      

    Ordinary Shares Voted Against

      

    Ordinary Shares Abstained

    21,626,815

      

    2,477,631

      

    165,721

    Proposal No. 8: The Director Election Proposal

     

    Names

       Ordinary Shares Voted For      Ordinary Shares Abstained  

    Class I Nominees:

         

    Eric Bjornholt

         21,984,003        2,286,164  

    Dawn Meyerriecks

         21,693,764        2,576,403  

    Class II Nominees:

         

    David Singer

         21,982,816        2,287,351  

    Kristina Johnson

         21,668,641        2,601,526  

    Class III Nominees:

         

    Matthew Kinsella

         21,979,366        2,290,801  

    Catherine Lego

         21,979,758        2,290,409  

    As there were sufficient votes to approve the above proposals, Proposal No. 9, the “Adjournment Proposal” described in the Proxy Statement was not presented to shareholders.

     

    Item 7.01

    Regulation FD Disclosure.

    On February 12, 2026, Churchill issued a press release announcing the approval of all of the proposals presented at the Shareholder Meeting. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated by reference herein.

    The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of Churchill X under the Securities Act of 1933, as amended or the Exchange Act, regardless of any general incorporation language in such filings. This Current Report on Form 8-K (this “Current Report”) will not be deemed an admission as to the materiality of any information in this Item 7.01, including Exhibit 99.1.

     


    Item 8.01

    Other Events.

    Shareholders holding 37,821 Class A Ordinary Shares, representing approximately 0.09% of the Class A Ordinary Shares outstanding, exercised their right to redeem such shares for a pro rata portion of the funds in the trust account resulting in only $388,453.90 (approximately $10.27 per share) being removed from the Company’s trust account to pay such shareholders. As a result, at close of the Business Combination, Churchill will deliver approximately $551.4 million of gross transaction proceeds to Infleqtion, consisting of approximately $424.8 million of proceeds from the trust account and $126.5 million of proceeds from Churchill’s previously announced private placement.

    Based on the approval of the Domestication Proposal at the Shareholder Meeting, on February 12, 2026, Churchill will effect a deregistration under the applicable provisions of Churchill’s current articles of association and Section 206 of the Companies Act (As Revised) of the Cayman Islands and a domestication under Section 388 of the Delaware General Corporation Law, pursuant to which Churchill’s jurisdiction of incorporation will change from the Cayman Islands to the State of Delaware. Effective upon the Domestication, the continuing entity will be renamed “Infleqtion, Inc.” and existing shareholders of Churchill will hold shares of common stock in Infleqtion, Inc. rather than ordinary shares in a Cayman Islands company.

    Based on the results of the Shareholder Meeting, and subject to the satisfaction or waiver of certain other closing conditions as described in the Proxy Statement, the transactions contemplated by the Merger Agreement are expected to be consummated promptly. In connection with the Business Combination, Churchill intends to apply to have the post-Business Combination company common stock listed on The New York Stock Exchange (“NYSE”) under the symbol “INFQ,” and the post-Business Combination company will change its name to “Infleqtion, Inc.” It is a condition to the consummation of the Business Combination that the shares of post-Business Combination company common stock to be issued (or reserved for issuance) in the Business Combination have been listed on NYSE or any other stock exchange mutually agreed upon by Churchill and Infleqtion and shall be eligible for continued listing immediately following the closing, but there can be no assurance that such listing condition will be met. If such listing condition is not met, the Business Combination will not be consummated unless the listing condition is waived by the parties to the Merger Agreement.

    Forward Looking Statements

    This Current Report includes “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Infleqtion has based these forward-looking statements on current expectations and projections about future events. These statements include: projections of market opportunity and market share; estimates of customer adoption rates and usage patterns; projections regarding Infleqtion’s ability to commercialize new products and technologies; projections of development and commercialization costs and timelines; expectations regarding Infleqtion’s ability to execute its business model and the expected financial benefits of such model; expectations regarding Infleqtion’s ability to attract, retain and expand its customer base; Infleqtion’s deployment of proceeds from capital raising transactions; Infleqtion’s expectations concerning relationships with strategic partners, suppliers, governments, state-funded entities, regulatory bodies and other third parties; Infleqtion’s ability to maintain, protect and enhance its intellectual property; future ventures or investments in companies, products, services or technologies; development of favorable regulations affecting Infleqtion’s markets; the potential benefits of the proposed transaction and expectations related to its terms and timing; and the potential for Infleqtion to increase in value.

    These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of Infleqtion and Churchill.

    These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause Infleqtion’s or Churchill’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such


    statements. Such risks and uncertainties include: that Infleqtion is pursuing an emerging technology, faces significant technical challenges and may not achieve commercialization or market acceptance; Infleqtion’s historical net losses and limited operating history; Infleqtion’s expectations regarding future financial performance, capital requirements and unit economics; Infleqtion’s use and reporting of business and operational metrics; Infleqtion’s competitive landscape; Infleqtion’s dependence on members of its senior management and its ability to attract and retain qualified personnel; Infleqtion’s concentration of revenue in contracts with government or state-funded entities; the potential need for additional future financing; Infleqtion’s ability to manage growth and expand its operations; potential future acquisitions or investments in companies, products, services or technologies; Infleqtion’s reliance on strategic partners and other third parties; Infleqtion’s ability to maintain, protect and defend its intellectual property rights; risks associated with privacy, data protection or cybersecurity incidents and related regulations; the use, rate of adoption and regulation of artificial intelligence and machine learning; uncertainty or changes with respect to laws and regulations; uncertainty or changes with respect to taxes, trade conditions and the macroeconomic environment; the combined company’s ability to maintain internal control over financial reporting and operate a public company; the possibility that required regulatory approvals for the proposed transaction are delayed or are not obtained, which could adversely affect the combined company or the expected benefits of the proposed transaction; the risk that shareholders of Churchill could elect to have their shares redeemed, leaving the combined company with insufficient cash to execute its business plans; the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement; the outcome of any legal proceedings or government investigations that may be commenced against Infleqtion or Churchill; failure to realize the anticipated benefits of the proposed transaction; the ability of Churchill or the combined company to issue equity or equity-linked securities in connection with the proposed transaction or in the future; and other factors described in Churchill’s filings with the SEC. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Infleqtion, Churchill or the combined company resulting from the proposed transaction with the SEC, including under the heading “Risk Factors.” If any of these risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. In addition, these statements reflect the expectations, plans and forecasts of Infleqtion’s and Churchill’s management as of the date of this communication; subsequent events and developments may cause their assessments to change. While Infleqtion and Churchill may elect to update these forward-looking statements at some point in the future, they specifically disclaim any obligation to do so. Accordingly, undue reliance should not be placed upon these statements.

    In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this communication, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. An investment in Churchill is not an investment in any of our founders’ or sponsors’ past investments, companies or affiliated funds. The historical results of those investments are not indicative of future performance of Churchill, which may differ materially from the performance of our founders’ or sponsors’ past investments.

     

    Item 9.01.

    Financial Statements and Exhibits.

    (d)

     

    Exhibit

    Number

      

    Description

    99.1    Press Release, dated February 12, 2026
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated: February 12, 2026

     

    CHURCHILL CAPITAL CORP X
    By:  

    /s/ Jay Taragin

    Name:   Jay Taragin
    Title:   Chief Financial Officer


    Exhibit 99.1

    Churchill Capital Corp X Shareholders Approve Business Combination with Infleqtion

    Nearly 100% of trust cash retained ahead of closing

    Over $550 million of gross proceeds to be delivered to Infleqtion

    Transaction expected to close February 13, 2026

    NEW YORK – February 12, 2026 – Churchill Capital Corp X (“Churchill X”) (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced that its shareholders have approved the previously announced business combination with Infleqtion, Inc. (“Infleqtion”), a global leader in quantum sensing and quantum computing powered by neutral-atom technology.

    At a special meeting held today, the business combination and all related proposals were approved with overwhelming support from Churchill X shareholders, with over 90% of votes cast at the meeting voting in favor of the business combination (the “Transaction”).

    The strong support from Churchill X’s shareholders is expected to result in Infleqtion receiving over $550 million of gross proceeds (the “Churchill X Proceeds”), including nearly 100% of the cash held in Churchill X’s trust account prior to the redemption deadline and more than $125 million of incremental capital raised through a common stock PIPE at the transaction valuation from leading existing Infleqtion stockholders and new institutional investors.

    Infleqtion expects to be well capitalized at closing, combining the Churchill X Proceeds with existing cash on hand to support continued execution. The strengthened balance sheet is expected to accelerate Infleqtion’s technology roadmap and product commercialization, expanding deployments across artificial intelligence, national security, and space while enabling additional real-world applications.

    Upon closing of the Transaction, Infleqtion will become the first publicly listed neutral-atom quantum technology company and the only public company with commercial leadership across both quantum computing and precision sensing.

    Based on the approval of the domestication proposal by Churchill X’s shareholders, Churchill X will effect a deregistration, pursuant to which Churchill’s jurisdiction of incorporation will change from

    the Cayman Islands to the State of Delaware. Effective upon the domestication, the continuing entity will be renamed “Infleqtion, Inc.” and existing shareholders of Churchill will hold shares in Infleqtion, Inc. rather than in a Cayman Islands company.

    Churchill X, whose shares of common stock, warrants and units are currently listed on The Nasdaq Stock Market LLC (“Nasdaq”), will delist from Nasdaq. Shares of common stock and warrants of the post-combination company, Infleqtion, Inc., will be listed on the New York Stock Exchange (“NYSE”) beginning on February 17, 2026, under the ticker symbols “INFQ” and “INFQ WS”, respectively. Prior to the closing of the Transaction, each of the units sold by Churchill X in its initial public offering will be separated into one Class A ordinary share and one-quarter of one warrant of Churchill X and will no longer be listed on Nasdaq following the closing of the Transaction. The NYSE listing and Nasdaq delisting are subject to the closing of the Transaction and fulfillment of all NYSE listing requirements.


    The closing is expected to occur on February 13, 2026, subject to satisfaction of customary closing conditions.

    About Infleqtion

    Infleqtion is a global leader in quantum sensing and quantum computing, powered by neutral-atom technology. Infleqtion designs and builds quantum computers, precision sensors, and quantum software for governments, enterprises, and research institutions. Infleqtion’s commercial portfolio includes quantum computers as well as quantum Radio Frequency (QRF) systems, quantum clocks, and inertial navigation solutions. Infleqtion is the partner of choice for governments and commercial customers seeking cutting-edge quantum capabilities. Infleqtion announced in September 2025 it plans to go public via a merger with Churchill Capital Corp X (NASDAQ: CCCX). For more information, visit Infleqtion.com or follow Infleqtion on LinkedIn, YouTube, and X.

    About Churchill Capital Corp X

    Churchill X (NASDAQ: CCCX) is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It may pursue an initial business combination target in any business or industry.

    Forward-Looking Statements

    This communication includes “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Churchill X and Infleqtion have based these forward-looking statements on current expectations and projections about future events. These statements include: projections of market opportunity and market share; estimates of customer adoption rates and usage patterns; projections regarding Infleqtion’s ability to commercialize new products and technologies; projections of development and commercialization costs and timelines; expectations regarding Infleqtion’s ability to execute its business model and the expected financial benefits of such model; expectations regarding Infleqtion’s ability to attract, retain and expand its customer base; Infleqtion’s deployment of proceeds from capital raising transactions; Infleqtion’s expectations concerning relationships with strategic partners, suppliers, governments, state-funded entities, regulatory bodies and other third parties; Infleqtion’s ability to maintain, protect and enhance its intellectual property; future ventures or investments in companies, products, services or technologies; development of favorable regulations affecting Infleqtion’s markets; the potential benefits of the proposed transaction and expectations related to its terms and timing; and the potential for Infleqtion to increase in value.

    These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of Infleqtion and Churchill X.


    These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause Infleqtion’s or Churchill X’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such statements. Such risks and uncertainties include: that Infleqtion is pursuing an emerging technology, faces significant technical challenges and may not achieve commercialization or market acceptance; Infleqtion’s historical net losses and limited operating history; Infleqtion’s expectations regarding future financial performance, capital requirements and unit economics; Infleqtion’s use and reporting of business and operational metrics; Infleqtion’s competitive landscape; Infleqtion’s dependence on members of its senior management and its ability to attract and retain qualified personnel; Infleqtion’s concentration of revenue in contracts with government or state-funded entities; the potential need for additional future financing; Infleqtion’s ability to manage growth and expand its operations; potential future acquisitions or investments in companies, products, services or technologies; Infleqtion’s reliance on strategic partners and other third parties; Infleqtion’s ability to maintain, protect and defend its intellectual property rights; risks associated with privacy, data protection or cybersecurity incidents and related regulations; the use, rate of adoption and regulation of artificial intelligence and machine learning; uncertainty or changes with respect to laws and regulations; uncertainty or changes with respect to taxes, trade conditions and the macroeconomic environment; Infleqtion’s ability to maintain internal control over financial reporting and operate a public company; the possibility that required regulatory approvals for the proposed transaction are delayed or are not obtained, which could adversely affect the combined company or the expected benefits of the proposed transaction; the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination agreement; the outcome of any legal proceedings or government investigations that may be commenced against Infleqtion or Churchill X; failure to realize the anticipated benefits of the proposed transaction; the ability of Churchill X or the combined company to issue equity or equity-linked securities in connection with the proposed transaction or in the future; and other factors described in Churchill X’s filings with the SEC. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Infleqtion or Churchill X resulting from the proposed transaction with the SEC, including under the heading “Risk Factors.” If any of these risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. In addition, these statements reflect the expectations, plans and forecasts of Infleqtion’s and Churchill X’s management as of the date of this communication; subsequent events and developments may cause their assessments to change. While Infleqtion and Churchill X may elect to update these forward-looking statements at some point in the future, they specifically disclaim any obligation to do so. Accordingly, undue reliance should not be placed upon these statements.

    In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this communication, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. An investment in Churchill X is not an investment in any of our founders’ or sponsors’ past investments, companies or affiliated funds. The historical results of those investments are not indicative of future performance of Churchill X, which may differ materially from the performance of our founders’ or sponsors’ past investments.


    Contacts

    Media Contact

    Tim Biba

    Solebury Strategic Communications

    [email protected]

    Investor Contact

    Marcus Kupferschmidt

    Infleqtion

    [email protected]

    Get the next $CCCX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCCX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCCX
    SEC Filings

    View All

    SEC Form SCHEDULE 13D filed by Churchill Capital Corp X

    SCHEDULE 13D - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/18/26 8:09:47 PM ET
    $CCCX
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Churchill Capital Corp X

    SCHEDULE 13G/A - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/17/26 4:47:39 PM ET
    $CCCX
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by Churchill Capital Corp X

    SCHEDULE 13D/A - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    2/17/26 4:30:03 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Infleqtion and Churchill Capital Corp X Complete Business Combination

    Infleqtion to become the first publicly listed neutral-atom quantum technology company and will begin trading on the NYSE under ticker symbol "INFQ" on February 17, 2026 Infleqtion, Inc. ("Infleqtion"), a global leader in quantum sensing and quantum computing powered by neutral-atom technology, today announced the completion of its previously announced business combination with Churchill Capital Corp X (NASDAQ:CCCX) ("Churchill X"), a special purpose acquisition company. Churchill X, whose shares of common stock, warrants and units were listed on The Nasdaq Stock Market LLC ("Nasdaq") has delisted from Nasdaq, and shares of common stock and warrants of the post‑combination company, Infl

    2/13/26 12:09:00 PM ET
    $CCCX
    Blank Checks
    Finance

    Churchill Capital Corp X Shareholders Approve Business Combination with Infleqtion

    Nearly 100% of trust cash retained ahead of closing Over $550 million of gross proceeds to be delivered to Infleqtion Transaction expected to close February 13, 2026 Churchill Capital Corp X ("Churchill X") (NASDAQ:CCCX), a publicly traded special purpose acquisition company, today announced that its shareholders have approved the previously announced business combination with Infleqtion, Inc. ("Infleqtion"), a global leader in quantum sensing and quantum computing powered by neutral-atom technology. At a special meeting held today, the business combination and all related proposals were approved with overwhelming support from Churchill X shareholders, with over 90% of votes cast at

    2/12/26 4:00:00 PM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion Founder & Chief Science Officer Dr. Dana Anderson Elected to the National Academy of Engineering

    Membership comes in recognition of Dr. Anderson's contributions to optical quantum engineering of ultracold atoms Infleqtion, a global leader in quantum sensing and quantum computing, develops atom-based quantum technology for commercial and government applications. Infleqtion is proud to announce the induction of Dr. Dana Anderson into the National Academy of Engineering (NAE) for contributions to optical quantum engineering of ultracold atoms. Infleqtion recently announced plans to go public through a merger with Churchill Capital Corp X (NASDAQ:CCCX). "I am honored to be a member of this year's National Academy of Engineering class," said Dr. Dana Anderson, Founder and Chief Science

    2/12/26 2:30:00 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Maverick Capital Ltd claimed ownership of 19,941,924 shares (SEC Form 3)

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    2/18/26 8:09:05 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 4 filed by Director Singer David B

    4 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    2/18/26 8:56:41 AM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 4 filed by Director Meyerriecks Dawn Clawson

    4 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    2/18/26 8:55:22 AM ET
    $CCCX
    Blank Checks
    Finance